drugset / Trial / NCT00958451
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an open label, single center, randomized, active comparator controlled study, comparing the effects of vitamin D replacement using oral ergocalciferol versus paricalcitol on parathyroid hormone (PTH) levels in patients with stage 3 and 4 CKD and vitamin D deficiency or insufficiency. The purpose of this study is to determine which of these two approaches is more successful.
Timeline
- Start
- 2009-07
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ergocalciferol | Small molecule | 50000 iu | Oral |
| Comparator | Paricalcitol | Other / unclassified | 1 ug | Oral |
| Comparator | Paricalcitol | Other / unclassified | 2 ug | Oral |